HHS launches fast molecular testing pilot
The Department of Health and Human Services recently distributed 27,000 portable COVID-19 molecular test kits, which Alaska, Florida, Louisiana, New Jersey, and Texas can use at the point of care to verify antigen test results within 20 minutes. The pilot program is part of a $481 million contract with Cue Health that HHS and the Department of Defense announced last month. The Food and Drug Administration in June authorized the testing system’s emergency use in patient care settings operating under a CLIA certificate of waiver, compliance or accreditation. “The pilot program will help us determine how well the Cue test will be adapted in institutions and communities,” said HHS Assistant Secretary for Health Brett Giroir, M.D.
Related News Articles
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…